Is Angiotensin-Converting Enzyme Inhibitor a Contraindication for Contrast-Induced Nephropathy Prophylaxis? A Review About its Paradox
Cardiovascular Therapeutics, 04/26/2012
Li X et al. – Authors review the medical literatures and discuss the pathogenesis, the role of renin–angiotensin–aldosterone system on the development of contrast–induced nephropathy (CIN) and angiotensin–converting enzyme (ACE) inhibitors' effect on CIN.